Showing results (21-30 of 232) with videos related to
Sort By:
Pageof 24
ACS Chemical Neuroscience|February 13, 2018
Gadolinium-Free Contrast Agents for Magnetic Resonance Imaging of the Central Nervous SystemEric M Gale, Peter CaravanMetallomics : Integrated Biometal Science|December 6, 2018
The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemistsMariane Le Fur, Peter CaravanCurrent Cardiovascular Imaging Reports|March 19, 2013
Molecular MRI of the Cardiovascular System in the Post-NSF EraDavid E Sosnovik, Peter CaravanCirculation. Cardiovascular Imaging|April 30, 2014
In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probeIlknur Ay, Francesco Blasi, Tyson A Rietz, et al.Magnetic Resonance in Medicine|February 11, 2010
Evidence for weak protein binding of commercial extracellular gadolinium contrast agentsYan Wang, Marga Spiller, Peter CaravanJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2015
Radiation Dosimetry of the Fibrin-Binding Probe ⁶⁴Cu-FBP8 and Its Feasibility for PET Imaging of Deep Vein Thrombosis and Pulmonary Embolism in RatsFrancesco Blasi, Bruno L Oliveira, Tyson A Rietz, et al.Investigative Radiology|October 19, 2020
Molecular MR Contrast AgentsSergey Shuvaev, Eman Akam, Peter CaravanEJNMMI Radiopharmacy and Chemistry|March 6, 2018
Metabolite profiling with HPLC-ICP-MS as a tool for in vivo characterization of imaging probesEszter Boros, Omar R Pinkhasov, Peter CaravanJournal of the American Chemical Society|March 21, 2013
Redox-activated manganese-based MR contrast agentGalen S Loving, Shreya Mukherjee, Peter CaravanRadiology|July 24, 2012
Science to practice: how will myocardial inflammation be imaged with MR imaging?David E Sosnovik, Matthias Nahrendorf, Peter CaravanPageof 24